Nanoform Finland OYJ Logo

Nanoform Finland OYJ

Offers nanoparticle engineering services to enhance drug performance for pharma clients.

NANOFH | ST

Overview

Corporate Details

ISIN(s):
FI4000330972
LEI:
743700JJO2NU8LBS1592
Country:
Finland
Address:
Viikinkaari 4, FI-00790 HELSINKI

Description

Nanoform is a nanoparticle medicine enabling company that provides expert services in drug particle engineering to the global pharmaceutical and biotech industries. The company utilizes its proprietary, scalable Controlled Expansion of Supercritical Solutions (CESS®) technology to enhance the performance of both small and large molecule therapeutics. By creating uniform nanoparticles, Nanoform's services aim to improve drug bioavailability and solubility, enable higher drug loading in smaller dosage forms, and facilitate novel delivery routes such as subcutaneous, long-acting injectable, and inhaled formulations. The company partners with clients throughout the drug development lifecycle to overcome formulation challenges and reduce clinical trial attrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nanoform Finland OYJ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nanoform Finland OYJ

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nanoform Finland OYJ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Farmsintez ao Logo
Develops and produces APIs and finished dosage forms; offers contract manufacturing.
Russian Federation
LIFE
FARON PHARMACEUTICALS OY Logo
Clinical-stage biopharmaceutical company developing immunotherapies for cancer.
Finland
FARN
FATE THERAPEUTICS INC Logo
Develops iPSC-derived cellular immunotherapies for cancer and autoimmune disorders.
United States of America
FATE
FENNEC PHARMACEUTICALS INC. Logo
Biopharmaceutical company focused on preventing hearing loss in pediatric oncology.
United States of America
FENC
FibroBiologics, Inc. Logo
A clinical-stage biotech developing fibroblast cell-based therapies for chronic diseases.
United States of America
FBLG
FIBROGEN INC Logo
Biopharmaceutical company developing therapeutics for anemia and oncology.
United States of America
FGEN
Fine Foods & Pharmaceuticals Ntm Logo
A CSDMO specializing in solid oral forms for the pharma and nutraceutical sectors.
Italy
FF
FITLIFE BRANDS, INC. Logo
Provider of nutritional supplements and wellness products for health-conscious consumers.
United States of America
FTLF
Flora Growth Corp. Logo
An international pharmaceutical distributor and digital assets treasury company.
United States of America
FLGC
FluoGuide A/S Logo
Develops fluorescent products to improve the precision of cancer surgery.
Denmark
FLUO

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.